Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells
Th17 cells are a newly found subset of distinct CD4+ Th effector cells’ family and are found to play an important role in cancers. Myelodysplastic syndromes (MDS) are a common malignant hematological disease. Here, we showed that both the percentage and the function of Th17 cells were elevated in lo...
Main Authors: | Jing Li, Lanzhu Yue, Huaquan Wang, Chunyan Liu, Hui Liu, Jinglian Tao, Weiwei Qi, Yihao Wang, Wei Zhang, Rong Fu, Zonghong Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/9404705 |
Similar Items
-
Effects of Shikonin on the Functions of Myeloid Dendritic Cells in a Mouse Model of Severe Aplastic Anemia
by: Mengying Zheng, et al.
Published: (2020-01-01) -
An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
by: Xinmin Wang, et al.
Published: (2021-03-01) -
Allogeneic Stem Cell Transplantation for MDS
by: Sara Villar, et al.
Published: (2021-08-01) -
Myeloid-derived suppressor cell cytokine secretion as prognostic factor in myelodysplastic syndromes
by: Dong Han, et al.
Published: (2020-11-01) -
CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
by: Fatih M. Uckun, et al.
Published: (2021-09-01)